Lexington Hill Partners, LLC

Position in LLY — ELI LILLY & Co

CIK 2111980 DALLAS, TX

Position in LLY

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$659,686

+$139,097 QoQ

Shares Held

550

-2.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.34%

of 13F equity value

Holder Rank

#3,513

of 4,605 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Lexington Hill Partners, LLC holds $1,858,828 across 5 Drug Manufacturers - General names. LLY ranks #1 (35.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	550	$659,686
2	ABBV	AbbVie Inc.	1,288	$324,112
3	JNJ	Johnson & Johnson	1,237	$314,160
4	MRK	Merck & Co., Inc.	2,328	$299,148
5	NVS	Novartis AG	1,670	$261,722

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$659,686	550	-2.8%	Shares	Sole	2026-07-08
2026-03-31	$520,589	566	+35.7%	Shares	Sole	2026-04-16
2025-12-31	$448,141	417	—	Shares	Sole	2026-02-19
No filing history on record for this holder in this stock.